XTL Biopharmaceuticals Ltd. (XTLB.TA)
ILA 4.8
(4.35%)
ILA 4.8
(4.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.4 Million USD | 33.09% |
| 2022 | -2.09 Million USD | 29.47% |
| 2021 | -2.96 Million USD | 18.23% |
| 2020 | -3.63 Million USD | 18.5% |
| 2019 | -4.45 Million USD | -36.87% |
| 2018 | -3.25 Million USD | 1.03% |
| 2017 | -3.28 Million USD | -62.9% |
| 2016 | -2.01 Million USD | 47.11% |
| 2015 | -3.81 Million USD | -76.79% |
| 2014 | -2.15 Million USD | 25.22% |
| 2013 | -2.88 Million USD | -70.22% |
| 2012 | -1.69 Million USD | -2509.23% |
| 2011 | -65 Thousand USD | 93.9% |
| 2010 | -1.06 Million USD | -158.74% |
| 2009 | -412 Thousand USD | 85.91% |
| 2008 | -2.92 Million USD | -23.01% |
| 2007 | -2.37 Million USD | 45.98% |
| 2006 | -4.4 Million USD | 67.07% |
| 2005 | -13.36 Million USD | -4.47% |
| 2004 | -12.78 Million USD | -205.64% |
| 2003 | -4.18 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.06 Million USD | 23.77% |
| 2023 Q1 | -1.9 Million USD | 9.07% |
| 2023 FY | -1.4 Million USD | 33.09% |
| 2023 Q4 | -1.4 Million USD | 3.84% |
| 2023 Q3 | -1.45 Million USD | 8.31% |
| 2023 Q2 | -1.58 Million USD | 16.54% |
| 2022 Q2 | -2.34 Million USD | 15.97% |
| 2022 FY | -2.09 Million USD | 29.47% |
| 2022 Q1 | -2.79 Million USD | 5.96% |
| 2022 Q4 | -2.09 Million USD | 5.93% |
| 2022 Q3 | -2.22 Million USD | 5.12% |
| 2021 Q3 | -3.01 Million USD | -3.19% |
| 2021 FY | -2.96 Million USD | 18.23% |
| 2021 Q1 | -3.39 Million USD | 6.53% |
| 2021 Q2 | -2.91 Million USD | 14.02% |
| 2021 Q4 | -2.96 Million USD | 1.39% |
| 2020 Q1 | -4.25 Million USD | 4.44% |
| 2020 Q3 | -3.75 Million USD | 6.83% |
| 2020 Q4 | -3.63 Million USD | 3.22% |
| 2020 FY | -3.63 Million USD | 18.5% |
| 2020 Q2 | -4.02 Million USD | 5.4% |
| 2019 Q1 | -5.06 Million USD | -55.51% |
| 2019 Q3 | -4.64 Million USD | 2.48% |
| 2019 Q2 | -4.76 Million USD | 5.97% |
| 2019 FY | -4.45 Million USD | -36.87% |
| 2019 Q4 | -4.45 Million USD | 4.03% |
| 2018 Q1 | -1.02 Million USD | 68.99% |
| 2018 Q3 | -1.08 Million USD | 4.49% |
| 2018 Q4 | -3.25 Million USD | -200.28% |
| 2018 FY | -3.25 Million USD | 1.03% |
| 2018 Q2 | -1.13 Million USD | -11.27% |
| 2017 Q3 | -6.08 Million USD | 3.79% |
| 2017 Q1 | -6.75 Million USD | -234.57% |
| 2017 FY | -3.28 Million USD | -62.9% |
| 2017 Q4 | -3.28 Million USD | 45.95% |
| 2017 Q2 | -6.32 Million USD | 6.37% |
| 2016 Q1 | -3.1 Million USD | 18.55% |
| 2016 FY | -2.01 Million USD | 47.11% |
| 2016 Q4 | -2.01 Million USD | 13.05% |
| 2016 Q3 | -2.32 Million USD | 10.86% |
| 2016 Q2 | -2.6 Million USD | 16.21% |
| 2015 FY | -3.81 Million USD | -76.79% |
| 2015 Q4 | -3.81 Million USD | 11.23% |
| 2015 Q3 | -4.3 Million USD | 10.79% |
| 2015 Q2 | -4.82 Million USD | -174.96% |
| 2015 Q1 | -1.75 Million USD | 18.81% |
| 2014 Q1 | -2.59 Million USD | 10.11% |
| 2014 FY | -2.15 Million USD | 25.22% |
| 2014 Q2 | -2.67 Million USD | -3.12% |
| 2014 Q3 | -2.36 Million USD | 11.77% |
| 2014 Q4 | -2.15 Million USD | 8.56% |
| 2013 Q1 | -1.66 Million USD | 49.61% |
| 2013 FY | -2.88 Million USD | -70.22% |
| 2013 Q4 | -2.88 Million USD | 30.33% |
| 2013 Q3 | -4.14 Million USD | -316.48% |
| 2013 Q2 | -995 Thousand USD | 40.38% |
| 2012 Q1 | -3.93 Million USD | -3098.37% |
| 2012 Q4 | -3.31 Million USD | -254.6% |
| 2012 Q2 | -1.41 Million USD | 63.93% |
| 2012 FY | -1.69 Million USD | -2509.23% |
| 2012 Q3 | -934 Thousand USD | 34.18% |
| 2011 Q3 | -200 Thousand USD | 21.88% |
| 2011 Q4 | -123 Thousand USD | 38.5% |
| 2011 FY | -65 Thousand USD | 93.9% |
| 2011 Q2 | -256 Thousand USD | 55.71% |
| 2011 Q1 | -578 Thousand USD | 45.78% |
| 2010 Q3 | -1.37 Million USD | -905.11% |
| 2010 FY | -1.06 Million USD | -158.74% |
| 2010 Q4 | -1.06 Million USD | 22.59% |
| 2010 Q2 | -137 Thousand USD | 45.42% |
| 2010 Q1 | -251 Thousand USD | 39.08% |
| 2009 Q4 | -412 Thousand USD | 35.63% |
| 2009 FY | -412 Thousand USD | 85.91% |
| 2009 Q3 | -640 Thousand USD | 0.0% |
| 2008 FY | -2.92 Million USD | -23.01% |
| 2008 Q4 | -2.92 Million USD | 0.0% |
| 2008 Q2 | -3.08 Million USD | 0.0% |
| 2007 Q4 | -2.37 Million USD | 0.0% |
| 2007 Q2 | -2.45 Million USD | 0.0% |
| 2007 FY | -2.37 Million USD | 45.98% |
| 2006 Q2 | -32.17 Million USD | 0.0% |
| 2006 FY | -4.4 Million USD | 67.07% |
| 2006 Q4 | -4.4 Million USD | 0.0% |
| 2005 Q4 | -13.36 Million USD | 0.0% |
| 2005 Q2 | -4.96 Million USD | 0.0% |
| 2005 FY | -13.36 Million USD | -4.47% |
| 2004 FY | -12.78 Million USD | -205.64% |
| 2004 Q4 | -12.78 Million USD | 0.0% |
| 2004 Q2 | -7.84 Million USD | 0.0% |
| 2003 FY | -4.18 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Matricelf Ltd | -835 Thousand ILA | -67.784% |